Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysis

Journal of Vascular Surgery

Volumn 47, Issue 2, 2008, Pages 461-469

  Mwipatayi, Bibombe Patrice ^a   Hockings, Alexandra ^a   Hofmann, Matthias ^a   Garbowski, Marek ^a   Sieunarine, Kishore ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BALLOON DILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMOROPOPLITEAL OCCLUSIVE DISEASE; FOLLOW UP; GRAFT PATENCY; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MEDICAL LITERATURE; META ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RESTENOSIS; REVIEW; SENSITIVITY ANALYSIS; STENT; SURVIVAL RATE; SYSTEMATIC REVIEW;

ANGIOPLASTY, BALLOON; ANKLE; ARTERIAL OCCLUSIVE DISEASES; BLOOD PRESSURE; BRACHIAL ARTERY; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL ARTERY; HUMANS; MALE; ODDS RATIO; POPLITEAL ARTERY; PROSTHESIS FAILURE; RECURRENCE; RISK ASSESSMENT; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 38649088264     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.07.059     Document Type: Review

References (33)

1. Bates M.C., and Aburahma A.F. An update on endovascular therapy of the lower extremities. J Endovasc Ther 11 Suppl 2 (2004) II107-II127
2. Wiesinger B., Heller S., Schmehl J., Claussen C.D., Wiskirchen J., and Tepe G. Percutaneous vascular interventions in the superficial femoral artery. A review. Minerva Cardioangiol 54 (2006) 83-93
3. Mewissen M.W. Stenting in the femoropopliteal arterial segment. Tech Vasc Interv Radiol 8 (2005) 146-149
4. Rigatelli G., Cardaioli P., and Giordan M. Endovascular treatment of femoro-popliteal obstructive disease. Minerva Cardioangiol 55 (2007) 125-132
5. Hunink M.G., and Wong J.B. Meta-analysis of failure-time data with adjustment for covariates. Med Decis Making 14 (1994) 59-70
6. Muradin G.S., Bosch J.L., Stijnen T., and Hunink M.G. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221 (2001) 137-145
7. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., and Fowkes F.G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 1 Suppl (2007) S5-S67
8. Adam D.J., and Bradbury A.W. TASC II document on the management of peripheral arterial disease. Eur J Vasc Endovasc Surg 33 (2007) 1-2
9. Brouwers M.C., Johnston M.E., Charette M.L., Hanna S.E., Jadad A.R., and Browman G.P. Evaluating the role of quality assessment of primary studies in systematic reviews of cancer practice guidelines. BMC Med Res Methodol 5 (2005) 8
10. Clark H.D., Wells G.A., Huet C., McAlister F.A., Salmi L.R., Fergusson D., et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials 20 (1999) 448-452
11. Moher D., Pham B., Jones A., Cook D.J., Jadad A.R., Moher M., et al. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 352 (1998) 609-613
12. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
13. Cantor A. Projecting the standard error of the Kaplan-Meier estimator. Stat Med 20 (2001) 2091-2097
14. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
15. Mahid S.S., Hornung C.A., Minor K.S., Turina M., and Galandiuk S. Systematic reviews and meta-analysis for the surgeon scientist. Br J Surg 93 (2006) 1315-1324
16. Schillinger M., Sabeti S., Loewe C., Dick P., Amighi J., Mlekusch W., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
17. Grenacher L., Saam T., Geier A., Muller-Hulsbeck S., Cejna M., Kauffmann G.W., et al. [PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA)]. Rofo 176 (2004) 1302-1310
18. Becquemin J.P., Favre J.P., Marzelle J., Nemoz C., Corsin C., and Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg 37 (2003) 487-494
19. Saxon R.R., Coffman J.M., Gooding J.M., Natuzzi E., and Ponec D.J. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 14 (2003) 303-311
20. Cejna M., Thurnher S., Illiasch H., Horvath W., Waldenberger P., Hornik K., et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 12 (2001) 23-31
21. Grimm J., Muller-Hulsbeck S., Jahnke T., Hilbert C., Brossmann J., and Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 12 (2001) 935-942
22. Bollinger A., and Schlumpf M. Andreas Gruntzig's balloon catheter for angioplasty of peripheral arteries (PTA) is 25 years old. VASA 28 (1999) 58-64
23. Matsi P.J., Manninen H.I., Soder H.K., Mustonen P., and Kouri J. Percutaneous transluminal angioplasty in femoral artery occlusions: primary and long-term results in 107 claudicant patients using femoral and popliteal catheterization techniques. Clin Radiol 50 (1995) 237-244
24. Alback A., Biancari F., Schmidt S., Mikkola P., Kantonen I., Matzke S., et al. Hemodynamic results of femoropopliteal percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 16 (1998) 7-12
25. Stanley B., Teague B., Raptis S., Taylor D.J., and Berce M. Efficacy of balloon angioplasty of the superficial femoral artery and popliteal artery in the relief of leg ischemia. J Vasc Surg 23 (1996) 679-685
26. Shah D.M., Darling III R.C., Chang B.B., Fitzgerald K.M., Paty P.S., and Leather R.P. Long-term results of in situ saphenous vein bypass. Analysis of 2058 cases. Ann Surg 222 (1995) 438-446 discussion 446-38
27. Aune S., Pedersen O.M., and Trippestad A. Surveillance of above-knee prosthetic femoropopliteal bypass. Eur J Vasc Endovasc Surg 16 (1998) 509-512
28. Pereira C.E., Albers M., Romiti M., Brochado-Neto F.C., and Pereira C.A. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg 44 (2006) 510-517
29. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
30. Duda S.H., Bosiers M., Lammer J., Scheinert D., Zeller T., Tielbeek A., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16 (2005) 331-338
31. Duda S.H., Bosiers M., Lammer J., Scheinert D., Zeller T., Oliva V., et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13 (2006) 701-710
32. Schlager O., Dick P., Sabeti S., Amighi J., Mlekusch W., Minar E., et al. Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 12 (2005) 676-684
33. Scheinert D., Scheinert S., Sax J., Piorkowski C., Braunlich S., Ulrich M., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005) 312-315